Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2009 2
2010 1
2011 1
2012 4
2013 2
2014 4
2015 4
2016 4
2017 7
2018 4
2019 11
2020 13
2021 16
2022 11
2023 7
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide.
Parikh M, Tangen C, Hussain MHA, Gupta S, Callis S, Jo Y, Harzstark A, Paller CJ, George S, Zibelman MR, Cheng HH, Maughan BL, Zhang J, Pachynski RK, Bryce AH, Lin DW, Quinn DI, Lerner SP, Thompson IM, Dorff TB, Lara PN, Agarwal N. Parikh M, et al. Among authors: paller cj. Eur Urol Oncol. 2024 Mar 23:S2588-9311(24)00054-3. doi: 10.1016/j.euo.2024.03.001. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38523017 Free article.
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.
Kumar R, Mendonca J, Shetty A, Yang Y, Owoyemi O, Wilson L, Boyapati K, Topiwala D, Thomas N, Nguyen H, Luo J, Paller CJ, Denmeade S, Carducci MA, Kachhap SK. Kumar R, et al. Among authors: paller cj. bioRxiv [Preprint]. 2024 Feb 16:2024.02.13.579966. doi: 10.1101/2024.02.13.579966. bioRxiv. 2024. PMID: 38405771 Free PMC article. Preprint.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Markowski MC, Taplin ME, Aggarwal R, Sena LA, Wang H, Qi H, Lalji A, Sinibaldi V, Carducci MA, Paller CJ, Marshall CH, Eisenberger MA, Sanin DE, Yegnasubramanian S, Gomes-Alexandre C, Ozbek B, Jones T, De Marzo AM, Denmeade SR, Antonarakis ES. Markowski MC, et al. Among authors: paller cj. Nat Commun. 2024 Jan 2;15(1):14. doi: 10.1038/s41467-023-44514-2. Nat Commun. 2024. PMID: 38167882 Free PMC article. Clinical Trial.
The ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients.
Visvanathan K, Petry D, McCullough MS, May B, Tenkasi R, Sharma N, Klein CA, Johnson A, Killian G, Camp M, Paller CJ, Couzi R, Wilkinson M, Jacobs L, Lange J, Jelovac D, Carducci MA, Habibi M, Naik G, Kotwaliwale A. Visvanathan K, et al. Among authors: paller cj. J Cancer Surviv. 2023 Dec 8. doi: 10.1007/s11764-023-01495-x. Online ahead of print. J Cancer Surviv. 2023. PMID: 38064163
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons.
Hernandez KM, Venkat A, Elbers DC, Bihn JR, Brophy MT, Do NV, La J, Liu Q, Prokhorenkov A, Metoki-Shlubsky N, Sung FC, Paller CJ, Fillmore NR, Grossman RL. Hernandez KM, et al. Among authors: paller cj. Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4):a006298. doi: 10.1101/mcs.a006298. Print 2023 Dec. Cold Spring Harb Mol Case Stud. 2024. PMID: 38050021 Free PMC article.
90 results